Forest Laboratories, Inc. Reports Fiscal Year Second Quarter 2014 Diluted Earnings Per Share of $0.26 Including Effect of $0.10 Per Share of Acquisition Amortization

Published: Oct 22, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Forest Laboratories, Inc. (NYSE:FRX), an international pharmaceutical manufacturer and marketer, today announced that reported diluted earnings per share equaled $0.26 in the second quarter of fiscal 2014. Reported diluted earnings per share in the second quarter of fiscal 2013 were $0.08. Excluding acquisition related amortization and specified items, non-GAAP EPS in the second fiscal quarter of 2014 equaled $0.36 compared with $0.15 per share in the second quarter of fiscal 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news